After the Senate passed an amended version of the legislation in November, the House pushed back against the changes. Now appointed lawmakers will meet to iron out differences between the chambers’ approaches and potentially send the House bill to the governor’s desk.
Among the revisions to the state’s cannabis law is a section that would increase the personal possession limit of marijuana from one ounce to two. Colorado enacted the same reform in 2021 after the state’s cannabis market matured.
Sen. Adam Gómez (D), said before the Senate vote that the increased ownership limit and other changes proposed in the bill would “modernize” the state’s cannabis laws.
Gómez and Rep. Daniel Donahue (D), chairman of the Joint Cannabis Policy Committee, will serve as lead negotiators for the newly formed conference committee to act on the marijuana bill.
Other congressmen include Sens. Joanne Comerford (D) and Peter Durant (R), as well as Reps. Carlos Gonzalez (D) and Michael Soter (R).
“When Massachusetts voters approved adult cannabis use, we made a commitment not just to legalize it, but to build a safe, fair and well-regulated industry,” Gómez said in November. “Seven years later, we have made great progress, but the landscape has changed and our laws must reflect what it is.”
In addition to expanding ownership, which is included in both chambers’ versions, the bill would reduce the size and revise the organization of the Cannabis Control Commission (CCC), updating the limits on marijuana business licenses.
In both versions, the CCC would consist of three members instead of the current five. The Senate bill would appoint two directly by the governor and one by the attorney general. The House proposed that the governor make all appointments. In both cases, the state treasurer would not be responsible for appointing committee members.
The Senate-passed legislation includes a reciprocity section that allows out-of-state medical marijuana patients to purchase cannabis products from Massachusetts dispensaries.
Gómez said the version of invoice The one passed by the Senate would “remove outdated requirements that force medical operations to vertically integrate.”
He argued that the state is “reinforcing” its commitment to a fair cannabis industry by, among other things, “supporting worker ownership models and guiding the commission to develop fair and transparent host community agreements.”
The Senate-passed legislation also directs the CCC to study the mental health impacts and long-term outcomes of marijuana use.
“This legislation is not about starting over. It is about building on what we have learned,” said Gómez. “It’s about making sure our laws keep pace with a growing industry while protecting consumers, helping small businesses and advancing equity.”
Senators approved several changes to the House bill in November, including requiring the CCC to conduct studies on marijuana demand and supply, excise tax rates and regulation of hemp-derived cannabinoids.
Other approved amendments direct regulators to update cannabis testing protocols annually and clarify “advertising, marketing and branding of sales, discounts and customer loyalty programs at a marijuana establishment or through an opt-in email list.”
After the Senate passed the revised bill, the House opposed the changes, bringing in conference committee appointments.
Regulators should also examine marijuana’s effectiveness in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). In addition, police and first responders in other jurisdictions will review laws and policies regarding the use of cannabis and “any other matter deemed relevant by the commission.”
Against the backdrop of that legislative effort, Massachusetts officials recently announced a campaign behind it An initiative to roll back the state’s marijuana legalization law has collected enough valid signatures to send the measure to members of parliament, before it goes to the voters to decide this year’s vote.
The campaign already had it He expressed confidence that he has obtained enough signatures to move forward. Members of Parliament will receive the proposal on January 7 at the beginning of the 2026 session, and they have until May 5 to act on it. If the Legislature decides not to pass it, the campaign would have to go through another round of petitions and get at least 12,429 certified signatures by July 1 to get on the November ballot.
Controversy has arisen over the prohibitionist coalition’s signature-gathering tactics, with petitioners working on behalf of the campaign allegedly sharing misleading information about what the measure would accomplish, paid petitioners using fake letters for other ballot measures on issues such as affordable housing and same-day voter registration.
The office of Massachusetts Attorney General Andrea Campbell (D), that is He cleared the signature collection campaign in September—stressed to voters the importance of reading their summary, which should go at the top of the signature form, before signing any petition.
Whether the cannabis measures make the cut remains to be seen. Voters approved legalization on the 2016 ballot, and sales began two years later. And in the last decade the market has evolved and expanded. In August, Massachusetts officials reported more than $8 billion in adult marijuana sales.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.
Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.
With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.
Rep. James Comer (R-KY) introduced the delay proposal as an amendment to the Farm Bill, while Rep. Mary Miller (R-IL) introduced an expedited approach. Neither will move forward, however, with Comer withdrawing his measure and the House Rules Committee failing to vote on Miller’s.
Hemp derivatives containing less than 0.3 percent delta-9 THC by weight of the drug were made federally legal under the 2018 Farm Bill signed by President Donald Trump in his first term. But late last year, Trump signed new legislation containing provisions that will redefine hemp so that only products with a total of 0.4 milligrams of THC per container will be legal starting Nov. 12.
Comer’s amendment, sponsored by Reps. Kelly Morrison (D-MN), Ilhan Omar (D-MN) and Morgan Griffith (R-VA), would have delayed the ban until November 2027.
According to Miller’s proposal, however, the ban will begin the day the new Farm Bill takes effect. However, it is unclear based on progress in Congress whether the large-scale farming legislation will actually become law, and the legislation could not pass until after the current recriminalization date.
Comer told the panel at Monday’s meeting that his amendment would “protect American farmers” and “help the hemp industry and the thousands of jobs that use and rely on these products.”
“It is clear that Congress needs more time to pass legislation that protects jobs, eliminates bad actors, standardizes labeling and requires third-party testing,” he said. “My amendment would give Congress another year, until November 2027, to develop this solution.”
It is not clear why he decided to remove it from the annex to the proposal Farm BillAlso known as the Farm, Food, and National Security Act of 2026, or HR 7567.
Griffith, a member of the Rules Committee who sponsored Comer’s amendment, noted that there are “a lot of hemp products from overseas that don’t have third-party testing” on the market, “frankly all kinds of junk.”
He said the real solution is for the Food and Drug Administration (FDA) to regulate the products, citing a separate bill he has introduced on the issue, but argued that “we have to have time to adjust,” which he said would provide the delay amendment.
Meanwhile, Rep. Andy Barr (R-KY) also introduced an amendment to the bill that, according to the sponsor’s summary, “changes the definition of hemp to protect the legal hemp market, creating a regulatory framework that protects children, bans synthetics, and ensures that products on the market are of American origin.”
The congressman later withdrew the proposal for undisclosed reasons.
Last week, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Barr, who is helping lead efforts to establish regulations for the plant as an alternative to prohibition.
“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.
“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”
The annex to the administration’s proposed legislative text has not been released publicly, and the White House and Barr’s office did not immediately respond to Marihuana Moment’s request for more details.
It’s not clear from the text of the letter whether the White House was proactively sending legislative proposals to the lawmaker or whether they were responding to something sent by his office, though two cannabis industry sources suggested to Marihuana Moment that Barr was sending the language to the administration, and then providing technical feedback.
“I’m calling on Congress to update the Act so Americans can continue to have access to the full-spectrum CBD products they trust and support, while maintaining Congress’ intent to restrict the sale of products that pose health risks,” the president said in a Truth Social message Thursday, the same day his administration announced it is moving forward to re-regulate marijuana.
“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”
The Farm Bill passed by the previous committee includes provisions to help the hemp industry and farmers who grow cannabis for industrial purposes, such as fiber and grain. For example, the legislation would amend statutes related to states and tribes developing regulatory plans for industrial hemp production, including policies on testing, sampling, background checks and record keeping.
Other bipartisan hemp reform bills are pending in Congress.
Ernst withdrew his name, however, as a sponsor of the legislation. His office did not respond to Marihuana Moment’s request for clarification on the move.
As hemp products become more popular among consumers, some big brands are trying to get in on the action.
The main retailer Target, for example, is expanding its involvement in the hemp-derived THC beverage market. Last year, the company began a pilot program in 10 stores in Minnesota that sell cannabis drinks. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
North Carolina lawmakers say they’re fueling debate over the state’s marijuana laws — a move by the Trump administration to reclassify it as a less dangerous drug.
Across the country, a set of laws and enforcements regulate marijuana. The drug is illegal under federal law, but dozens of US states have legalized it. And almost all states have legalized medical marijuana prescriptions for certain ailments. North Carolina is among the remaining states to resist any form of legalization. Republican politicians in North Carolina have resisted passing any bills to legalize or decriminalize marijuana, despite public opinion polls showing broad public support for such changes.
Senate President Phil Berger said he expects his chamber to revisit efforts to legalize medical marijuana this week. “We will have a conversation within our caucus if they are interested in whether we do something,” Berger told reporters Tuesday.
The recent actions of Republican President Donald Trump may add a new dimension to these conversations. Trump’s acting attorney general on Thursday signed the drug classification as a less dangerous and less strictly regulated drug than marijuana. Federal law does not legalize marijuana for medical or recreational use.